Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

424 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Micafungin Breakthrough Fungemia in Patients with Hematological Disorders.
Kimura M, Araoka H, Yamamoto H, Nakamura S, Nagi M, Yamagoe S, Miyazaki Y, Ogura S, Mitsuki T, Yuasa M, Kaji D, Kageyama K, Nishida A, Taya Y, Shimazu H, Ishiwata K, Takagi S, Yamamoto G, Asano-Mori Y, Uchida N, Wake A, Taniguchi S, Yoneyama A. Kimura M, et al. Among authors: yuasa m. Antimicrob Agents Chemother. 2018 Apr 26;62(5):e02183-17. doi: 10.1128/AAC.02183-17. Print 2018 May. Antimicrob Agents Chemother. 2018. PMID: 29530846 Free PMC article.
A Novel Reduced-Toxicity Myeloablative Conditioning Regimen Using Full-Dose Busulfan, Fludarabine, and Melphalan for Single Cord Blood Transplantation Provides Durable Engraftment and Remission in Nonremission Myeloid Malignancies.
Yamamoto H, Uchida N, Yuasa M, Kageyama K, Ota H, Kaji D, Nishida A, Ishiwata K, Takagi S, Tsuji M, Asano-Mori Y, Yamamoto G, Izutsu K, Masuoka K, Wake A, Yoneyama A, Makino S, Taniguchi S. Yamamoto H, et al. Among authors: yuasa m. Biol Blood Marrow Transplant. 2016 Oct;22(10):1844-1850. doi: 10.1016/j.bbmt.2016.06.017. Epub 2016 Jun 21. Biol Blood Marrow Transplant. 2016. PMID: 27345142 Free article.
Breakthrough viridans streptococcal bacteremia in allogeneic hematopoietic stem cell transplant recipients receiving levofloxacin prophylaxis in a Japanese hospital.
Kimura M, Araoka H, Yoshida A, Yamamoto H, Abe M, Okamoto Y, Yuasa M, Kaji D, Kageyama K, Nishida A, Ishiwata K, Takagi S, Yamamoto G, Asano-Mori Y, Uchida N, Hishinuma A, Izutsu K, Wake A, Taniguchi S, Yoneyama A. Kimura M, et al. Among authors: yuasa m. BMC Infect Dis. 2016 Aug 5;16:372. doi: 10.1186/s12879-016-1692-y. BMC Infect Dis. 2016. PMID: 27495798 Free PMC article.
Clinical and Microbiological Characteristics of Breakthrough Candidemia in Allogeneic Hematopoietic Stem Cell Transplant Recipients in a Japanese Hospital.
Kimura M, Araoka H, Yamamoto H, Asano-Mori Y, Nakamura S, Yamagoe S, Ohno H, Miyazaki Y, Abe M, Yuasa M, Kaji D, Kageyama K, Nishida A, Ishiwata K, Takagi S, Yamamoto G, Uchida N, Izutsu K, Wake A, Taniguchi S, Yoneyama A. Kimura M, et al. Among authors: yuasa m. Antimicrob Agents Chemother. 2017 Mar 24;61(4):e01791-16. doi: 10.1128/AAC.01791-16. Print 2017 Apr. Antimicrob Agents Chemother. 2017. PMID: 28115352 Free PMC article.
The Long-term Outcomes after VAD plus SCT Therapy in a Patient with AL Amyloidosis and Severe Factor X Deficiency.
Iwadate D, Hasegawa E, Hoshino J, Hayami N, Sumida K, Yamanouchi M, Sekine A, Kawada M, Hiramatsu R, Suwabe T, Sawa N, Yuasa M, Wake A, Fujii T, Ohashi K, Takaichi K, Ubara Y. Iwadate D, et al. Among authors: yuasa m. Intern Med. 2018 Mar 1;57(5):701-706. doi: 10.2169/internalmedicine.9263-17. Epub 2017 Nov 1. Intern Med. 2018. PMID: 29093408 Free PMC article.
No post-transplant pure red cell aplasia development in 106 major ABO incompatible cord blood transplantation.
Wada S, Asano-Mori Y, Yamamoto H, Yuasa M, Kageyama K, Kaji D, Nishida A, Ishiwata K, Takagi S, Yamamoto G, Uchida N, Yoneyama A, Makino S, Taniguchi S. Wada S, et al. Among authors: yuasa m. Bone Marrow Transplant. 2019 May;54(5):765-768. doi: 10.1038/s41409-018-0375-2. Epub 2018 Nov 6. Bone Marrow Transplant. 2019. PMID: 30401968 Clinical Trial. No abstract available.
Splenomegaly Negatively Impacts Neutrophil Engraftment in Cord Blood Transplantation.
Yuasa M, Yamamoto H, Kageyama K, Kaji D, Taya Y, Takagi S, Yamamoto G, Asano-Mori Y, Wake A, Yoneyama A, Makino S, Uchida N, Taniguchi S. Yuasa M, et al. Biol Blood Marrow Transplant. 2020 Sep;26(9):1689-1696. doi: 10.1016/j.bbmt.2020.05.018. Epub 2020 Jun 4. Biol Blood Marrow Transplant. 2020. PMID: 32505808 Free article.
HHV-6 associated diseases are one of the major factors on higher early CNS complications in CB recipients than in those of BM/PBSC.
Kageyama K, Uchida N, Yamamoto H, Takagi S, Ebihara M, Yuasa M, Kaji D, Nishida A, Ishiwata K, Yamamoto G, Asano-Mori Y, Izutsu K, Wake A, Yoneyama A, Makino S, Taniguchi S. Kageyama K, et al. Among authors: yuasa m. Bone Marrow Transplant. 2021 Mar;56(3):686-688. doi: 10.1038/s41409-020-01028-5. Epub 2020 Aug 11. Bone Marrow Transplant. 2021. PMID: 32782352 No abstract available.
Prognostic Impact of Cytogenetic Evolution on the Outcome of Allogeneic Stem Cell Transplantation in Patients with Acute Myeloid Leukemia in Nonremission: A Single-Institute Analysis of 212 Recipients.
Yuasa M, Yamamoto H, Mitsuki T, Kageyama K, Kaji D, Taya Y, Nishida A, Ishiwata K, Takagi S, Yamamoto G, Asano-Mori Y, Wake A, Koike Y, Makino S, Uchida N, Taniguchi S. Yuasa M, et al. Biol Blood Marrow Transplant. 2020 Dec;26(12):2262-2270. doi: 10.1016/j.bbmt.2020.08.026. Epub 2020 Aug 29. Biol Blood Marrow Transplant. 2020. PMID: 32871257 Free article.
424 results